Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Info & Links
CEO
Christian O. Henry
Headquarters
1305 O'BRIEN DRIVE MENLO PARK, CA 94025, UNITED STATES
Pacific Biosciences of California, Inc. Statistics
Valuation Measures
Market Capitalization2
310.84M
Enterprise Value
1.13B
Enterprise Value/EBITDA(ttm)
-4.09
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
2.92
Price to Book(mrq)
0.99
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
21.75%
Operating Margin(ttm)
-148.03%
Profit Margin(ttm)
-243.80%
Return on Equity(ttm)
-42.89%
Return on Invested Capital(ttm)
-27.24%
Return on Assets(ttm)
-14.77%
Income Statement
Revenue(ttm)
173.15M
Revenue Per Share(ttm)
0.63
Gross Profit(ttm)
36.80M
EBITDA(ttm)3
-274.95M
Net Income Available to Common(ttm)
-394.24M
Diluted EPS(ttm)
-1.64
Share Statistics
Beta (5Y Monthly)
1.92
52-Week Change
-69.73%
S&P 500 52-Week Change
7.42%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
273.86M
Dividend Yield
0.00%
Float4
267.29M
% Held by Insiders
2.40%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
471.84M
Total Cash Per Share(mrq)
1.72
Total Debt(mrq)
893.14M
Total Debt/Equity(mrq)
197.11%
Current Ratio(mrq)
9.74%
Quick Ratio(mrq)
8.64%
Book Value Per Share(mrq)
1.65
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.64
Free Cash Flow(ytd)
-179.98M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.